MOSCOW (MRC) -- Mitsui Chemicals, a Japanese chemical company, has announced a further expansion of its dental material business with acquisition of 50.01% of issued and outstanding shares of DENTCA, Inc. on June 20, 2013, reported the company in its press-release.
"Mitsui Chemicals, in line with one of its strategies in the FY2011 Mid-term Business Plan, has expanded its portfolio in businesses resilient to changing economic conditions such as healthcare," stated Minoru Koshibe, Mitsui Chemicals Executive Vice President. "As part of this strategy, Mitsui Chemicals targets active expansion including M&As, such as this April’s acquisition of the dental materials business of German Heraeus Holdings GmbH, which has a global manufacturing and sales network."
The dentures market is expected to continue to grow leveraged by the increase in aging of world-wide populations and rising incomes in emerging countries.
Mitsui Chemicals targets expansion of its global denture business through DENTCA's cutting-edge denture design technology using CAD/CAM and its own advanced material development and processing technology to develop high-performance dentures that meet global needs. In addition, both parties will benefit from the synergistic effect brought by the abundant selection of dental-related materials of Heraeus Dental.
As MRC informed earlier, Mitsui Chemicals Inc. detailed its 1 April 2013 organizational restructuring intended to support further acceleration of its portfolio transformation and implementation of safety directives. The plan involves restructuring of research and development, strengthening its safety management structure and restructuring of the Finance and Accounting Division.
DENTCA, with its head office in the United States, develops, manufactures, and distributes dentures using new cutting edge computer-aided design (CAD), computer aided manufacturing (CAM) technology, and proprietary 3-Dimensional modeling and printing technology.
Mitsui Chemicals,a Japanese chemical company, is a part of the Mitsui conglomerate. The company has a turnover of around 15 billion USD and has business interests in Japan, Europe, China, Southeast Asia and the USA. Mitsui Chemicals’ business portfolio includes petrochemicals, basic chemicals, polyurethanes, functional polymeric materials, functional chemicals, and films and sheets.
MRC